Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,517 Cr₹1,559 Cr₹871 Cr₹1,075 Cr₹671 Cr

What is the latest Sundry Debtors ratio of GLAND PHARMA ?

The latest Sundry Debtors ratio of GLAND PHARMA is ₹1,517 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,517 Cr
Mar2024₹1,559 Cr
Mar2023₹871 Cr
Mar2022₹1,075 Cr
Mar2021₹671 Cr

How is Sundry Debtors of GLAND PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,517 Cr
-2.70
Mar2024 ₹1,559 Cr
78.87
Mar2023 ₹871 Cr
-18.93
Mar2022 ₹1,075 Cr
60.19
Mar2021 ₹671 Cr -

Compare Sundry Debtors of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹32,617.2 Cr -3.5% 5.6% -3.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,864.0 Cr -4.3% -3% -0.7% Stock Analytics
DIVIS LABORATORIES ₹168,811.0 Cr -3.3% -7.4% 34.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,352.0 Cr 1.4% 10.1% 17.9% Stock Analytics
CIPLA ₹121,260.0 Cr -4.4% -0.5% 0.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,786.0 Cr -5.2% -5.7% -5.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-3.5%

5.6%

-3.6%

SENSEX

-1.1%

-3.4%

-1.1%


You may also like the below Video Courses